D.R. Horton, Inc.’s Stock Price Slumps to $129.00, Marking a 4.99% Drop: Is it Time to Buy?

D.R. Horton, Inc. (DHI)

129.00 USD -6.77 (-4.99%) Volume: 6.91M

D.R. Horton, Inc.’s stock price is currently standing at 129.00 USD, experiencing a dip of -4.99% this trading session with a trading volume of 6.91M. The leading homebuilding company in the US has seen a year-to-date percentage change of -7.74%, reflecting its dynamic market performance.

Latest developments on D.R. Horton, Inc.

Today, investors are closely monitoring the stock price movements of D.R. Horton Inc. (NYSE:DHI) after the company recently made a significant purchase of 281 lots in Delta Shores from Taylor Builders. Despite outperforming its competitors on a strong trading day, the stock underperformed on Thursday, prompting some to question if now is the time to consider buying shares in this leading home construction company. With the stock currently trading at US$139, many are adding D.R. Horton Inc. to their watch list as they anticipate potential shifts in the market.

D.R. Horton, Inc. on Smartkarma

Analysts at Baptista Research have been closely following Dr Horton Inc on Smartkarma, providing in-depth insights into the company’s financial performance. In their report titled “D.R. Horton: Adaptation to Market Trends Powering Our Bullishness! – Major Drivers,” they highlighted the company’s earnings of $2.61 per diluted share for the first quarter of fiscal 2025. Despite a slight decrease from the previous year, Dr Horton Inc still managed to generate consolidated revenues of $7.6 billion and a pretax profit margin of 14.6%. This positive outlook reflects the analysts’ bullish sentiment towards the company.

In another report by Baptista Research, titled “D.R. Horton: How Are They Adapting Pricing and Incentives in Response to Market Conditions? – Major Drivers,” analysts discussed the company’s performance in the fiscal year and quarter ending in 2024. Despite facing market challenges, Dr Horton Inc, America’s largest homebuilder, reported strong revenue figures with consolidated revenue reaching $10 billion and a pre-tax profit margin of 17.1%. This consistent profitability metric year-over-year showcases the company’s resilience and ability to adapt to changing market conditions, further boosting analysts’ bullish lean towards Dr Horton Inc.

A look at D.R. Horton, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for Dr Horton Inc, the company seems to have a positive long-term outlook. With strong scores in Growth and Resilience, it indicates that the company is well-positioned for future expansion and able to withstand economic challenges. While the Value and Momentum scores are not as high, the overall picture painted by the Smart Scores suggests that Dr Horton Inc has potential for continued success in the construction and sale of single-family homes.

D.R. Horton, Inc. focuses on constructing and selling single-family homes in various regions of the United States, catering to both entry-level and move-up markets. With a solid score in Growth and Resilience, the company appears to be on a path of steady development and able to adapt to market fluctuations. Although the Dividend and Momentum scores are not as high, Dr Horton Inc‘s overall outlook, as indicated by the Smart Scores, points towards a promising future in the homebuilding industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma